Cargando…
Prevalence and Pattern of Resistance in NS5A/NS5B in Hepatitis C Chronic Patients Genotype 3 Examined at a Public Health Laboratory in the State of São Paulo, Brazil
PURPOSE: Globally, it is estimated that 71 million people are chronically infected with hepatitis C, and 10–20% of these will develop cirrhosis and hepatocellular carcinoma. The development of new direct-acting antiviral (DAA) drugs has contributed to sustained virological response (SVR), eliminatin...
Autores principales: | de Torres Santos, Ana Paula, Martins Silva, Vanessa Cristina, Mendes-Corrêa, Maria Cássia, Lemos, Marcilio Figueiredo, de Mello Malta, Fernanda, Santana, Rúbia Anita Ferraz, Dastoli, Gregório Tadeu Fernando, de Castro, Vanessa Fusco Duarte, Pinho, João Renato Rebello, Moreira, Regina Célia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917774/ https://www.ncbi.nlm.nih.gov/pubmed/33658809 http://dx.doi.org/10.2147/IDR.S247071 |
Ejemplares similares
-
Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis
por: Santos, Ana Paula de Torres, et al.
Publicado: (2022) -
Hepatitis B in the Northwestern region of Sao Paulo State: genotypes
and resistance mutations
por: Meneghello, Brígida Helena da Silva, et al.
Publicado: (2021) -
Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus
por: Tavares, Rita Chelly Felix, et al.
Publicado: (2018) -
Distribution of hepatitis B virus subgenotype F2a in São Paulo, Brazil
por: Alvarado-Mora, Mónica V, et al.
Publicado: (2013) -
Treatment of chronic HCV infection with DAAs in Rio de Janeiro/Brazil: SVR rates and baseline resistance analyses in NS5A and NS5B genes
por: Costa, Vanessa D., et al.
Publicado: (2019)